English | Español

Technology/Innovation
+ Technology/Innovation
Patient Daily Report | May 23, 2023

Dr. Janet Maynard: new FDA-approved drug will 'provide an additional safe and effective option for women' experiencing hot flashes
+ Community
Patient Daily Report | May 22, 2023

Local doctor on balloon sinuplasty: 'This procedure is minimally invasive, safe, painless, fast and effective'
+ Technology/Innovation
Patient Daily | May 22, 2023

Vizzia Technologies Achieves SOC 2 Type II Compliance Certification for RTLS
+ Technology/Innovation
Pacient Daily | May 22, 2023

Krystal Biotech Receives FDA Approval for the First-Ever Redosable Gene Therapy, VYJUVEK™ (beremagene geperpavec-svdt) for the Treatment of Dystrophic Epidermolysis Bullosa
+ Technology/Innovation
Pacient Daily | May 22, 2023

Clinical ink Work Demonstrating Technology Sensitivity to Parkinson’s Disease Published in Nature
+ Technology/Innovation
Patient Daily | May 22, 2023

Loxo@Lilly Announces Details of Presentations at 2023 European Hematology Association (EHA) Annual Meeting
Patient Daily Report | May 22, 2023

Dr. Lakkireddy: 'Assert-IQ ICM is a significant advancement amongst the tools that are currently available for diagnoses of irregular heart rhythms'
Patient Daily Report | May 21, 2023

MyFitnessPal: 'Our community will now have the critical capability to understand and visualize how the foods they eat affect their blood glucose levels'

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation